Biotricity is trading at $0.06, down 11.43%, with no specific catalyst identified.
- No company announcement or specific catalyst was identified for September 29, 2026; Biotricity’s newsroom lists February 11, 2026, as its latest press release.
- Healthcare shares are weak: supplied sector context shows XLV down 1.33%, while major indexes are mixed. Sector weakness may be contributing, but does not establish the cause of Biotricity’s larger decline.